Patent · US Active

Method of treating an inflammatory bowel disease comprising agonists of orexin-1 receptor

US10172921B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
UNIVERSITÉ PARIS DIDEROT—PARIS 7 · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR

Inventors

Alain COUVINEAU · Paris, FR
Thierry VOISIN · Paris, FR
Nassima MESSAL · Paris, FR
Eric OGIER-DENIS · Paris, FR
Xavier TRETON · Paris, FR

Key dates

Filing date	Jun 23, 2015
Grant date	Jan 8, 2019
Priority date	—
Expiry date	Jun 23, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases. The presents methods relates to a method of treating an inflammatory bowel disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R agonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.